Clinical and ultrasound markers of significant liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease and arterial hypertension
Objective — to identify clinical, laboratory, and ultrasound markers of significant liver fibrosis in patients with metabolic dysfunction‑associated steatotic liver disease (MASLD) and arterial hypertension. Materials and methods. The study was conducted at two healthcare institutions and had a prospective design. Pat...